Skip to content
← Back to this collection

PUBLICATIONS · 18626004

Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2008 Sep 20
First author
Robinson KS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Robinson KS
      type
      Author
    2. name
      Williams ME
      type
      Author
    3. name
      van der Jagt RH
      type
      Author
    4. name
      Cohen P
      type
      Author
    5. name
      Herst JA
      type
      Author
    6. name
      Tulpule A
      type
      Author
    7. name
      Schwartzberg LS
      type
      Author
    8. name
      Lemieux B
      type
      Author
    9. name
      Cheson BD
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Robinson KS
      type
      Author
    2. name
      Williams ME
      type
      Author
    3. name
      van der Jagt RH
      type
      Author
    4. name
      Cohen P
      type
      Author
    5. name
      Herst JA
      type
      Author
    6. name
      Tulpule A
      type
      Author
    7. name
      Schwartzberg LS
      type
      Author
    8. name
      Lemieux B
      type
      Author
    9. name
      Cheson BD
      type
      Author
    bibliography ids
    1. nci-bib-fa1edc9b9d707b126d604eaa
    book metadata
    content sha256
    6956e82332866f14dcf4f099d10bc9e2b9e858e2af19f99b47e7db61cc5e3662
    document type
    citation
    dois
    1. 10.1200/JCO.2008.17.0001
    electronic publication date
    display
    2008 Jul 14
    precision
    day
    year
    2008
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:18626004
    immutable id
    pubmed:18626004@6956e82332866f14dcf4f099d10bc9e2b9e858e2af19f99b47e7db61cc5e3662
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    27
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    4473-9
    volume
    26
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      18626004
      provenance
      batch id
      6281e3e555c9a831cffc
      provider
      NCBI PubMed ESummary
      record sha256
      8bd15112d0711faf9fe031f5922eadcc4017e118bd38848ae263cadd9e35e61b
      response sha256
      0bb4ba3914464c472d4206a84abe8224c9e76dc003114204593648964c5bf66c
      retrieved at
      2026-09-09T23:46:21.772457+00:00
      publication date
      display
      2008 Sep 20
      precision
      day
      year
      2008
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/18626004/
      title
      Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.

      Preserved source evidence · Independent clinical review pending · Not medical advice